Home > Insider Trading > Filing (0001209191-20-019776)

Filing Details

Accession Number:: 0001209191-20-019776
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-17 19:07:57
Reporting Period:: 2020-03-13

Accepted Time:: 2020-03-17 19:07:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1653087	Alector Inc.	ALEC	Biological Products, (No Disgnostic Substances) (2836)	462702363

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1757964	Robert Paul	C/O Alector, Inc. 131 Oyster Point Blvd, Suite 600 South San Francisco CA 94080	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-03-13	1,481	$21.57	262,238	No	4	S	Direct
Common Stock	Disposition	2020-03-13	2,884	$22.47	259,354	No	4	S	Direct
Common Stock	Disposition	2020-03-13	5,459	$23.49	253,895	No	4	S	Direct
Common Stock	Disposition	2020-03-13	176	$24.46	253,719	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $21.03 to $22.01 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $22.03 to $23.02 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $23.06 to $24.02 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $24.30 to $24.68 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.